We are live on
!
Find out more
AstraZeneca
AZN
AZN
454 hedge funds and large institutions have $12.7B invested in AstraZeneca in 2017 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 171 increasing their positions, 123 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
39% more repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 123
20% more call options, than puts
Call options by funds: $165M | Put options by funds: $138M
3% more capital invested
Capital invested by funds: $12.3B → $12.7B (+$430M)
0.57% more ownership
Funds ownership: 14.25% → 14.82% (+0.57%)
2% less funds holding
Funds holding: 465 → 454 (-11)
11% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 54
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
454
Holders Change
-11
Holders Change %
-2.37%
% of All Funds
11.32%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
48
Increased
171
Reduced
123
Closed
54
Calls
$165M
Puts
$138M
Net Calls
+$27M
Net Calls Change
-$291M
Top Buyers
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$208M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$177M |
| 3 |
Jennison Associates
New York
|
-$67.6M |
| 4 |
Goldman Sachs
New York
|
-$37.7M |
| 5 |
Barclays
London,
United Kingdom
|
-$28M |